Document is current
Any future updates will be listed below
-
Authors
Schmartz, Georges P.
Rehner, Jacqueline http://orcid.org/0000-0003-1335-4898
Gund, Madline P. http://orcid.org/0000-0001-9053-8864
Keller, Verena
Molano, Leidy-Alejandra G. http://orcid.org/0000-0003-0069-6098
Rupf, Stefan
Hannig, Matthias
Berger, Tim
Flockerzi, Elias http://orcid.org/0000-0002-0423-3624
Seitz, Berthold http://orcid.org/0000-0001-9701-8204
Fleser, Sara
Schmitt-Grohé, Sabina
Kalefack, Sandra
Zemlin, Michael http://orcid.org/0000-0001-9528-7419
Kunz, Michael http://orcid.org/0000-0001-9666-2209
Götzinger, Felix
Gevaerd, Caroline
Vogt, Thomas
Reichrath, Jörg
Diehl, Lisa
Hecksteden, Anne
Meyer, Tim
Herr, Christian http://orcid.org/0000-0001-9422-6569
Gurevich, Alexey
Krug, Daniel http://orcid.org/0000-0002-3664-1884
Hegemann, Julian http://orcid.org/0000-0002-3859-8744
Bozhueyuek, Kenan http://orcid.org/0000-0002-8609-2967
Gulder, Tobias A. M. http://orcid.org/0000-0001-6013-3161
Fu, Chengzhang http://orcid.org/0000-0002-3513-4768
Beemelmanns, Christine http://orcid.org/0000-0002-9747-3423
Schattenberg, Jörn M. http://orcid.org/0000-0002-4224-4703
Kalinina, Olga V. http://orcid.org/0000-0002-9445-477X
Becker, Anouck
Unger, Marcus
Ludwig, Nicole
Seibert, Martina
Stein, Marie-Louise
Hanna, Nikolas Loka
Martin, Marie-Christin
Mahfoud, Felix http://orcid.org/0000-0002-4425-549X
Krawczyk, Marcin http://orcid.org/0000-0002-0113-0777
Becker, Sören L. http://orcid.org/0000-0003-3634-8802
Müller, Rolf http://orcid.org/0000-0002-1042-5665
Bals, Robert
Keller, Andreas http://orcid.org/0000-0002-5361-0895
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 13 September 2024
First Online: 26 September 2024
Competing interests
: G.P.S., R.M., and A.K. are co-founders of MooH GmbH, a company developing metagenomic based oral health tests. FM is supported by Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche Herzstiftung. His institution (Saarland University) has received scientific support from Ablative Solutions, Medtronic, and ReCor Medical. He has received speaker honoraria/consulting fees from Ablative Solutions, Amgen, Astra-Zeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and Terumo. The remaining authors declare no competing interests.
